Weekend roundup: Campbell in the soup | New cancer gene therapy | Exposing bad investment advice – MarketWatch
MarketWatch |
Weekend roundup: Campbell in the soup | New cancer gene therapy | Exposing bad investment advice
MarketWatch Novartis AG NVS, -0.27% received FDA approval for the first cancer gene therapy available in the U.S. Emma Court explained how important this is for young people suffering from a type of acute lymphoblastic leukemia (ALL), and she interviewed Janney … |
